Tag Archives: PTAB

IPO Webinar on PTAB Discretion

The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "PTAB Discretion: Exploring the New Metes and Boundaries" on May 23, 2019 from 2:00 to 3:00 pm (ET). Orion Armon of Cooley LLP, Kirby Lee of Ecolab, and … Continue reading

Posted in Intellectual Property | Tagged , , | Leave a comment

Federal Circuit Affirms PTAB Ruling That Prior Art and FDA Skepticism Supports Non-Obviousness Finding

The U.S. Court of Appeals for the Federal Circuit recently affirmed the Patent Trial and Appeal Board’s (PTAB’s) decision upholding the patentability of Eli Lilly & Co.’s patent claims directed to reducing toxicity of a chemotherapy agent. In so holding, … Continue reading

Posted in Technology & Cyberlaw | Tagged , , , , , , , , , | Leave a comment

Shutting Down the PTAB with Forum Selection Clauses

CAFC Upholds Injunction to Shut Down PTAB The AIA statutes provide that a person who is not the owner of a patent, can challenge the patent at the Patent Trial & Appeal Board (PTAB). Pursuant to the bright lines drawn … Continue reading

Posted in Intellectual Property | Tagged , , , , , | Leave a comment

PTAB Determines that RPI Designation is Not a Statutory Requirement After All

Precedent Indicates Mistaken RPI Correctable Without Date Reset A few weeks back I pointed out that the Patent Trial & Appeal Board (PTAB) had changed its position on whether or not a new RPI designation requires a resetting of the petition … Continue reading

Posted in Intellectual Property | Tagged , , , , | Leave a comment

PTAB Estoppel Thwarts Post-Trial Invalidity Consideration

Timing of Estoppel Unimportant Last week in Novartis Pharmaceutical Corp. v. Par Pharmaceutical Inc., Nos. 14-1289-RGA, 14-1494-RGA, 15-0078-RGA (D. Del. Apr. 11, 2019), (here) the court addressed a motion to estop defendants from asserting invalidity arguments based on prior art references already … Continue reading

Posted in Intellectual Property | Tagged , , , | Leave a comment